Gameto Inc., a biotech company working on stem-cell therapies for women’s health, has raised $44 million in venture capital to help fund a clinical trial for its product that aims to improve the ...

As birth rates decline and US IVF access falls further behind, Gameto recruits first Phase 3 patients for cutting-edge biotechnology to reignite reproductive health possibilities Company's $127 ...

Article ‘Count’ and ‘Share’ for Gameto Inc. based on listed parameters only. The articles listed below published by authors from Gameto Inc., organized by journal and article, represent the research ...

AUSTIN, Texas, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Gameto, a clinical-stage biotechnology company advancing cell engineering solutions for women’s health, today announced that it has exclusively ...

AUSTIN, Texas--(BUSINESS WIRE)--Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S. Food and Drug Administration (FDA) has ...

Gameto plans to use the iPSC line to advance its program, Fertilo, designed to improve IVF and egg freezing. NEW YORK, Oct. 4, 2023 /PRNewswire/ -- REPROCELL Inc. today announced that it has entered ...

Investing.com -- Biotech company Gameto Inc. has secured $44 million in venture capital funding to advance its stem-cell therapy aimed at improving the egg-freezing experience for women, Bloomberg ...